Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 1,002 put options on the company.
RBC Capital analyst Conor McNamara maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report) on February 4 and set a ...
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
Zacks.com on MSN2d
MCK Stock Before Q3 Earnings: A Smart Buy or Risky Investment?McKesson Corporation MCK is scheduled to report third-quarter fiscal 2025 results on Feb. 5, after market close. The company ...
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).
Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...
Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...
View Maravai LifeSciences Holdings, Inc. (MRVI) current and estimated P/E ratio data provided by Seeking Alpha.
Over the last 7 days, the United States market has risen by 3.8%, contributing to a 24% climb over the past year, with earnings expected to grow by 15% annually. In such a dynamic environment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback